Michelle Monje, MD, PhD is a pediatric neuro-oncologist, a professor of Neurology and Neurological Sciences and a Howard Hughes Medical Institute Investigator at Stanford University. Her research program focuses on DIPG and other diffuse midline gliomas at the intersection of neuroscience, immunology and brain cancer biology. Dr. Monje has led several of her discoveries from basic molecular work to clinical trials. She has been recognized with numerous honors, including an NIH Director’s Pioneer Award, a MacArthur Fellowship and election to the National Academy of Medicine.